The molecular pathogenesis and management of bronchial carcinoids.

Journal article

INTRODUCTION: In terms of well-differentiated neuroendocrine tumors (NETs), the lung is the second most common site of occurrence, after the gastro-entero-pancreatic axis, and comprises ∼ 25% of all NETs which may occur in various parts of the body. Pulmonary NETs are classified into four groups including typical carcinoid tumors, atypical carcinoid tumors, small cell lung carcinoma and large cell neuroendocrine carcinomas. Among pulmonary NETs, typical and atypical carcinoid tumors of the l...

Expand abstract

Authors: Cakir, M; Grossman, A

• Publication status: Published
• Journal: Expert opinion on therapeutic targets
• Volume: 15
• Issue: 4
• Pages: 457-491
• Publication date: 2011-04-01
• DOI: 10.1517/14728222.2011.555403
• EISSN: 1744-7631
• ISSN: 1472-8222
• Language: English
• Keywords: Bronchial Neoplasms; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Lung Neoplasms; Carcinoid Tumor; Small Cell Lung Carcinoma; Lung; Signal Transduction; Carcinoma, Small Cell; Molecular Targeted Therapy; Antineoplastic Agents; Humans